Literature DB >> 6809843

Relationship between the specificity of IgA proteases and serotypes in Haemophilus influenzae.

M H Mulks, S J Kornfeld, B Frangione, A G Plaut.   

Abstract

Haemophilus influenzae is one of five bacterial species known to produce IgA proteases, enzymes that specifically cleave the human IgA1 heavy chain. Strains of H. influenzae produce three distinct types of IgA proteases that cleave different peptide bonds within the IgA1 hinge region. Type 1 protease cleaves the prolyl-seryl bond at position 231-232; type 2 protease cleaves the prolyl-threonyl bond at position 235-236, the same bond attacked by Neisseria gonorrhoeae and Neisseria meningitidis type 2 proteases. Type 3 protease yields a unique double Fd cleavage pattern; the exact peptide bonds cleaved have not been determined. The type of protease produced correlates with the serotype, but not with the biotype, of the isolate; serotypes A, B, D, and F produce primarily type 1 protease, whereas serotypes C and E produce only type 2 enzyme. Each nontypable strain yields one of the three protease types. These data further extend our knowledge of the extreme specificity of the IgA proteases and suggest that IgA protease type may be useful in the taxonomy and epidemiology of H. influenzae.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6809843     DOI: 10.1093/infdis/146.2.266

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

1.  Haemophilus influenzae immunoglobulin A1 protease genes: cloning by plasmid integration-excision, comparative analyses, and localization of secretion determinants.

Authors:  F J Grundy; A Plaut; A Wright
Journal:  J Bacteriol       Date:  1987-10       Impact factor: 3.490

2.  A Comparison between Two Pathophysiologically Different yet Microbiologically Similar Lung Diseases: Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.

Authors:  Daniel E Fenker; Cameron T McDaniel; Warunya Panmanee; Ralph J Panos; Eric J Sorscher; Carleen Sabusap; John P Clancy; Daniel J Hassett
Journal:  Int J Respir Pulm Med       Date:  2018-11-29

3.  Localization of the cleavage site specificity determinant of Haemophilus influenzae immunoglobulin A1 protease genes.

Authors:  F J Grundy; A G Plaut; A Wright
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

4.  Expression of IgA Proteases by Haemophilus influenzae in the Respiratory Tract of Adults With Chronic Obstructive Pulmonary Disease.

Authors:  Timothy F Murphy; Charmaine Kirkham; Megan M Jones; Sanjay Sethi; Yong Kong; Melinda M Pettigrew
Journal:  J Infect Dis       Date:  2015-05-20       Impact factor: 5.226

5.  Evolutionary genetics of the encapsulated strains of Haemophilus influenzae.

Authors:  J M Musser; J S Kroll; E R Moxon; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

6.  Purification, characterization, and comparison of the immunoglobulin A1 proteases of Neisseria gonorrhoeae.

Authors:  D A Simpson; R P Hausinger; M H Mulks
Journal:  J Bacteriol       Date:  1988-04       Impact factor: 3.490

Review 7.  Pathogenesis and pathophysiology of bacterial meningitis.

Authors:  A R Tunkel; W M Scheld
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

8.  Secreted proteases from Actinobacillus pleuropneumoniae serotype 1 degrade porcine gelatin, hemoglobin and immunoglobulin A.

Authors:  E Negrete-Abascal; V R Tenorio; J J Serrano; C Garcia; M de la Garza
Journal:  Can J Vet Res       Date:  1994-04       Impact factor: 1.310

9.  Purification and characterization of an immunoglobulin A1 protease from Bacteroides melaninogenicus.

Authors:  S B Mortensen; M Kilian
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

10.  Active-site gating regulates substrate selectivity in a chymotrypsin-like serine protease the structure of haemophilus influenzae immunoglobulin A1 protease.

Authors:  Troy A Johnson; Jiazhou Qiu; Andrew G Plaut; Todd Holyoak
Journal:  J Mol Biol       Date:  2009-04-23       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.